COVID-19 may deplete testosterone, helping to explain male patients' poorer prognosis

Over half of male patients studied were found to have lower than their normal testosterone levels
28-Sep-2020 5:10 PM EDT, by Taylor & Francis

Newswise — For the first time, data from a study with patients hospitalized due to COVID-19 suggest that the disease might deteriorate men's testosterone levels.

Publishing their results in the peer-reviewed journal The Aging Male, experts from the University of Mersin and the Mersin City Education And Research Hospital in Turkey found as men's testosterone level at baseline decreases, the probability for them to be in the intensive care unit (ICU) significantly increases.

Lead author Selahittin Çayan, Professor of Urology, states that while it has already been reported that low testosterone levels could be a cause for poor prognosis following a positive SARS-CoV-2 test, this is the first study to show that COVID-19 itself depletes testosterone.

It is hoped that the development could help to explain why so many studies have found that male prognosis is worse than those females with COVID-19, and therefore to discover possible improvement in clinical outcomes using testosterone-based treatments.

"Testosterone is associated with the immune system of respiratory organs, and low levels of testosterone might increase the risk of respiratory infections. Low testosterone is also associated with infection-related hospitalisation and all-cause mortality in male in ICU patients, so testosterone treatment may also have benefits beyond improving outcomes for COVID-19," Professor Çayan explains.

"In our study, the mean total testosterone decreased, as the severity of the COVID-19 increased. The mean total testosterone level was significantly lower in the ICU group than in the asymptomatic group. In addition, the mean total testosterone level was significantly lower in the ICU group than in the Intermediate Care Unit group. The mean serum follicle stimulating hormone level was significantly higher in the ICU group than in the asymptomatic group.

"We found, Hypogonadism - a condition in which the body doesn't produce enough testosterone -in 113 (51.1%) of the male patients.

"The patients who died, had significantly lower mean total testosterone than the patients who were alive.

"However, even 65.2% of the 46 male patients who were asymptomatic had a loss of loss of libido."

The research team looked at a total of 438 patients. This included 232 males, each with laboratory confirmed SARS-CoV-2. All data were prospectively collected. A detailed clinical history, complete physical examination, laboratory and radiological imaging studies were performed in every patient. All data of the patients were checked and reviewed by the two physicians.

The cohort study was divided into three groups: asymptomatic patients (n: 46), symptomatic patients who were hospitalized in the internal medicine unit (IMU) (n: 129), and patients who were hospitalized in the intensive care unit (ICU) (n: 46).

In the patients who had pre-COVID-19 serum gonadal hormones test (n: 24), serum total testosterone level significantly decreased from pre-COVID-19 level of 458?±?198?ng/dl to 315?±?120?ng/dl at the time of COVID-19 in the patients (p?=?0.003).

Death was observed in 11 of the male adult patients (4.97%) and 7 of the female patients (3.55%), revealing no significance between the two genders (p?>?0.05).

Commenting on the results of the study, Professor Çayan added: "It could be recommended that at the time of COVID-19 diagnosis, testosterone levels are also tested. In men with low levels of sex hormones who test positive for COVID-19, testosterone treatment could improve their prognosis. More research is needed on this."

The limitations of this study include it not including a control group of patients with conditions other than COVID-19, this was due to the restrictions placed on the hospital that they were monitoring the patients in.

The authors state future studies should look at the concentration levels of ACE2 (Angiotensin-converting enzyme 2) - an enzyme attached to the cell membranes of cells located in the intestines -, in relationship with the total testosterone levels.

###

SEE ORIGINAL STUDY




Filters close

Showing results

1120 of 4204
access_time Embargo lifts in 2 days
Embargo will expire: 10-Dec-2020 12:00 PM EST Released to reporters: 3-Dec-2020 1:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2020 12:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Chicago neighborhoods with barriers to social distancing had higher COVID-19 death rates
Released: 3-Dec-2020 11:55 AM EST
Chicago neighborhoods with barriers to social distancing had higher COVID-19 death rates
University of Illinois at Chicago

New research has found that Chicago neighborhoods with barriers to social distancing, including limited access to broadband internet and low rates of health insurance, had more COVID-19 deaths in spring 2020. The study, led by researchers at the University of Illinois Chicago, is published in the Annals of Epidemiology.

Released: 3-Dec-2020 9:45 AM EST
Nearly Half of Community Health Center Patients Qualify for Phase One COVID-19 Vaccinations
George Washington University

Nearly half of all patients served by community health centers (CHCs) qualify for phase one COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention, according to a new analysis produced by researchers at the Geiger Gibson/RCHN Community Health Foundation Research Collaborative.

Released: 3-Dec-2020 9:00 AM EST
Sociologists Available to Discuss Vaccines and COVID-19
American Sociological Association (ASA)

As coronavirus cases rage throughout the United States—killing more than a quarter million in the U.S.—news of the effectiveness of vaccine candidates provides hope.

access_time Embargo lifts in 2 days
Embargo will expire: 8-Dec-2020 11:00 AM EST Released to reporters: 3-Dec-2020 8:30 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Dec-2020 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: The Medical Minute: Helping young athletes return to play safely after COVID-19
Released: 3-Dec-2020 8:20 AM EST
The Medical Minute: Helping young athletes return to play safely after COVID-19
Penn State Health

Young athletes in central Pennsylvania can’t wait to start basketball and wrestling season. But with the COVID-19 pandemic raging, parents wonder how their children can stay safe. And, if their child gets COVID-19, parents wonder when it’s safe for that child to get back to competitive sports.

Released: 2-Dec-2020 6:05 PM EST
How Caregivers of People with Dementia Can Navigate Holidays During the Pandemic
Rutgers University-New Brunswick

As COVID-19 cases increase across the nation, many caregivers are trying to navigate the holidays for relatives with dementia or Alzheimer’s disease. The Centers for Disease Control and Prevention suggests that people not travel to limit the potential spread of the coronavirus. Mary Catherine Lundquist, program director of Care2Caregivers, a peer counseling helpline (800-424-2494) for caregivers of people with dementia and Alzheimer’s disease operated by Rutgers Behavioral Health Care, discusses how families can stay connected with their loved ones.

Released: 2-Dec-2020 3:50 PM EST
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Fred Hutchinson Cancer Research Center

SEATTLE – Dec. 2, 2020 – Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.If you’re following the American Society of Hematology’s annual meeting (virtual, Dec. 5-8), see our media tip sheet highlighting Fred Hutch presentations and activities, including those by current ASH president Dr.

Newswise: “This is how we can help” – Couple shares their story as COVID-19 clinical trial participants
Released: 2-Dec-2020 2:35 PM EST
“This is how we can help” – Couple shares their story as COVID-19 clinical trial participants
University of Texas Health Science Center at Houston

“I don’t feel so great,” my husband, Brandon, said to me one Saturday afternoon – the last thing I wanted to hear after spending the last seven months tuned into COVID-19 media coverage. Knowing a few of his co-workers had recently tested positive for the virus, we didn’t wait to secure an appointment for a rapid test. When he called me an hour later to tell me he has tested positive, my heart sank.


Showing results

1120 of 4204

close
1.2681